Animal cell Cultures - Expression and Engineering
9. Danish Conference on Biotechnology and Molecular Biology
PLEASE NOTE: Registration at www.biokemi.org
Over the last fifty years research in cell biotechnology has revealed substantial potentials for the production of bioactive proteins and use of the cells themselves particularly in medical applications. The development of efficient and safe processes for production of novel pharmaceuticals is of significant industrial importance and subject to extensive research efforts. The increasing availability of genome editing tools and genome sequences of mammalian cell factories, such as the Chinese hamster ovary cell, and other animal cell cultures enables for the first time a systems biotechnology driven approach to cell factory design.
The conference will focus on
- Perspectives in Animal Cell Factory Research
- Expression and production systems
- Technology platforms
- Systems biology
- Post translational modifications
- Mammalian Cell Factories
- Insect Cell Factories
- Commercial perspectives and regulatory issues
- Carsten Hjort, Novozymes A/S, DK
- Gyun Min Lee, KAIST, KOR
- Henrik Clausen, Department of Cellular and Molecular Biology, Copenhagen University, DK
- Jakob Helding Rasmussen, Novo Nordisk A/S, DK
- Jens Gram, CMC Biologics, DK
- Jon Chesnut, Life Technologies, USA
- Kai M. Touw, Crucell, NL
- Kevin Kayser, Sigma, USA
- Martin Bonde, Dansk Biotek , DK
- Martin Dufva, Department of Micro- and Nanotechnology, Technical University of Denmark, DK
- Michael Betenbaugh, Johns Hopkins University ,USA
- Mikael Rørdam Andersen, Department of Systems Biology, Technical University of Denmark, DK
- Nicole Borth, University of Natural Resources and Life Sciences, AUT
- Terry Papoutsakis, University of Delaware, USA
- Yves Durocher, Animal Cell Technology Research Group, National Research Council, CAN
- Wian de Jongh, ExpreS2ion Biotechnologies, DK
- Svend Kjær, London Research Institute, UK
The conference includes a poster session covering a broad range of topics on biotechnology as well as a commercial exhibition of equipment, consumables and services to Danish biotechnology.
The conference is organised in collaboration with Danish Society of Biochemistry and Molecular Biology as well as BioPeople.
Secretariat: Birgitte Magnér-Egeberg, IDA Netværkscenter, Kalvebod Brygge 31 - 33, DK-1780 Copenhagen V, Phone: 33 18 46 46, e-mail: email@example.com.
Danish Biotechnological Society (DBS) is a scientific society established in 2006 in collaboration between Danish Biotechnology Forum and The Danish Society for Biochemistry and Molecular Biology. DBS is organised as part of The Danish Society of Engineers, IDA. The purpose of DBS is to facilitate networking within the field of biotechnology in Denmark, creating links between universities, research institutions, hospitals and companies. DBS represents professionals working with biotechnology and seeks to promote and communicate important issues on biotechnology, biochemistry and molecular biology to the public. DBS organises scientific conferences and meetings on biotechnology.
Working group members
- Anders Vagnø Pedersen, ALK-Abelló A/S
- Catharina Stenholm, Novozymes A/S
- Inge Kjærbølling, Society for Biological Engineering at Technical University of Denmark
- Jens Gram, CMC Biologics
- Jochen Förster, Technical University of Denmark
- Lars Haastrup Pedersen, Aalborg University
- Leif Schauser, CLC Bio
- Nils Joakim Færgeman, University of Southern Denmark
- Steen Gammeltoft, Glostrup Hospital
- Stephanie Mesker, Technical University of Denmark
- Thomas Schou Larsen, Biopeople – Innovation
- Uffe Hasbro Mortensen, Technical University of Denmark
Få højt specialiseret viden og rabat på arrangementer, som medlem af IDAs 40 fagtekniske netværk.